Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
University of Utah Health Science Center Gastroenterology
1510
mi
from 43215
Salt Lake City, UT
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
University of Utah Health Science Center Gastroenterology
1510
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
Hospital General de Agudos Juan Antonio Fernandez; infectología
5384
mi
from 43215
Buenos Aires,
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
Hospital General de Agudos Juan Antonio Fernandez; infectología
5384
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
All Children'S Hospital; Pediatric Blood & Marrow Transplant Program
843
mi
from 43215
Saint Petersburg, FL
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
All Children'S Hospital; Pediatric Blood & Marrow Transplant Program
843
mi
from 43215
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants, Llc
792
mi
from 43215
Orlando, FL
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants, Llc
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated:  12/31/1969
Washington University; Wash Uni. Sch. Of Med
397
mi
from 43215
Saint Louis, MO
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
Status: Enrolling
Updated: 12/31/1969
Washington University; Wash Uni. Sch. Of Med
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1972
mi
from 43215
Paramount, CA
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1972
mi
from 43215
Paramount, CA
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2040
mi
from 43215
Sacramento, CA
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2040
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
779
mi
from 43215
Newton, KA
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
779
mi
from 43215
Newton, KA
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
198
mi
from 43215
Bardstown, KY
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
198
mi
from 43215
Bardstown, KY
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
795
mi
from 43215
Metairie, LA
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
795
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
683
mi
from 43215
Omaha, NE
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
683
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1755
mi
from 43215
Henderson, NV
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1755
mi
from 43215
Henderson, NV
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
129
mi
from 43215
Cleveland, OH
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
937
mi
from 43215
Fort Worth, TX
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1136
mi
from 43215
San Angelo, TX
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1136
mi
from 43215
San Angelo, TX
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2031
mi
from 43215
Coquitlam,
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2031
mi
from 43215
Coquitlam,
Click here to add this to my saved trials
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
397
mi
from 43215
Saint Louis, MO
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
UCLA Pediatric Infectious Diseases
1972
mi
from 43215
Los Angeles, CA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
UCLA Pediatric Infectious Diseases
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital Blood Donor Center
1154
mi
from 43215
Aurora, CO
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital Blood Donor Center
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College
477
mi
from 43215
New York, NY
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
AIDS Clinical Trials Unit, NYU School of Medicine
479
mi
from 43215
New York, NY
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
AIDS Clinical Trials Unit, NYU School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Clinical Translational Research Center (CTRC) at UNC Hospitals
328
mi
from 43215
Chapel Hill, NC
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Clinical Translational Research Center (CTRC) at UNC Hospitals
328
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
AIDS Clinical Trial Unit, Holmes Hospital, Div of Infectious Disease, University of Cincinnati College of Medicine
97
mi
from 43215
Cincinnati, OH
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
AIDS Clinical Trial Unit, Holmes Hospital, Div of Infectious Disease, University of Cincinnati College of Medicine
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Ctr
1973
mi
from 43215
Los Angeles, CA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Ctr
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
2006
mi
from 43215
Seattle, WA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
659
mi
from 43215
Fayetteville, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
659
mi
from 43215
Fayetteville, AR
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1953
mi
from 43215
Anaheim, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1953
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
4501
mi
from 43215
Honolulu, HI
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
4501
mi
from 43215
Honolulu, HI
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
188
mi
from 43215
Louisville, KY
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
524
mi
from 43215
Charleston, SC
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1511
mi
from 43215
Salt Lake City, UT
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
620
mi
from 43215
Dothan, AL
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
620
mi
from 43215
Dothan, AL
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
644
mi
from 43215
Benton, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
644
mi
from 43215
Benton, AR
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
506
mi
from 43215
Jonesboro, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
506
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
625
mi
from 43215
Little Rock, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
625
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2070
mi
from 43215
Antioch, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2070
mi
from 43215
Antioch, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2112
mi
from 43215
Daly City, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2112
mi
from 43215
Daly City, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1966
mi
from 43215
Fountain Valley, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1966
mi
from 43215
Fountain Valley, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2088
mi
from 43215
Fremont, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2088
mi
from 43215
Fremont, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1986
mi
from 43215
Fresno, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1986
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2094
mi
from 43215
Hayward, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2094
mi
from 43215
Hayward, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2094
mi
from 43215
Oakland, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2094
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2101
mi
from 43215
Redwood City, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2101
mi
from 43215
Redwood City, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2029
mi
from 43215
Roseville, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2029
mi
from 43215
Roseville, CA
Click here to add this to my saved trials